Newspaper article from our research archive:

San Jose Mercury News, Calif., Vindu Goel column: Vindu's View: FDA more cautious than compassionate.(Column)

Byline: Vindu Goel

Oct. 10--If you were dying of cancer and there were an experimental drug that could give you an extra six months to live, you'd want access to it.

You'd still want it even if it had awful side effects, like turning your skin green and making your fingernails fall off -- which can happen to people taking Xcytrin, a drug from a Sunnyvale company that shows promise for treating brain lesions caused by the spread of lung cancer.

But is it the government's responsibility to make it easier for you to get such life-prolonging therapies, even if they cost tens of thousands of dollars a year?

That's the question the Food and Drug Administration, ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!